Re: Can Always Ask Tim
Posted: Wed Oct 13, 2021 6:24 pm
Cody with all love and respect you are on the wrong tangent. Merck has nothing to do with us - I don't see the "pill" as any kind of competition whatsoever. Listen to me carefully. The Jadicell Phase 3 is not to have an "approved" covid-19 therapy. It is to seek final approval to treat lung disease in the general public - things like COPD, emphysema, bronchitis, asthma, and yes ARDS. Do you know there are hundreds of ARDS cases every single day in the USA that have nothing to do with covid-19? Covid-19 ARDS is merely the vehicle to get there so don't burden yourself worrying about something that isn't even in the same class of drugs (a living drug) as JadiCell.
Codycrusher wrote: ↑Wed Oct 13, 2021 4:47 pm So Tim, I have a concern to share that many shareholders now share and I am not negative and still loading the boat, this has nothing to do with the share price but this is a legit concern.
So there is many businesses working on cures for covid lung damage/ARDS and Merck is 1 of them, they beat us to EUA filing so that feels like they are already ahead of the curve as our competitor, that is not good for our Jadicell covid lung damage/ARDS treatment, I assume there is more pharma and other businesses also working on covid lung damage cures so I think TSOI is on a timeline before we are screwed with our Jadicell for lung damage, any thoughts?
anything to worry about?
Simply put, I am more or less emphasizing on the timeline, it’s been 2 or almost 2 months since TSOI has begun working on jadicell for EUA and we haven’t even begun clinical trials yet, we don’t have unlimited time to get this to market, if it takes 1 year to get clinical trials began for example, that is just an example, we’re gonna be screwed, i am simply sharing my thoughts that I think things need to start, clinical trials need to be started, I feel like and us investors feel like you need to get the money pronto, not wait 2 months or more for the share price to hit .1
because I don’t think that we have time to waste and I think this waiting is going to hurt our science because we have competitors and they are starting to just run past us. It’s like a jog, whoever makes it to the finish line wins, TSOI needs to jog faster.
I only speak for Jadicell covid lung damage/ARDS, I feel and I have the concern along with the majority of investors, we are on a timeline, if things don’t move along at a fast enough pace we are going to miss the bus, our Jadicell for specifically covid lung damage will become useless.
What if Covid goes away in 2 years and a different disease with a different name is a disease we are dealing with than, our Jadicell would have to go through an entire brand new phase 1-2 and 3 for a brand new different named disease for example, there is no guarantee covid will be around in 2 years, or 3 so I think that we are running out of time if clinical trials don’t get started.
I respect you with the Utmost Tim, you are great, I just needed to share my concern.
Respectfully, your loyal investor and friend cody.